1. Home
  2. CENN vs LYRA Comparison

CENN vs LYRA Comparison

Compare CENN & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CENN
  • LYRA
  • Stock Information
  • Founded
  • CENN 2013
  • LYRA 2005
  • Country
  • CENN United States
  • LYRA United States
  • Employees
  • CENN N/A
  • LYRA N/A
  • Industry
  • CENN Auto Manufacturing
  • LYRA Medical/Dental Instruments
  • Sector
  • CENN Consumer Discretionary
  • LYRA Health Care
  • Exchange
  • CENN Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • CENN 13.8M
  • LYRA 11.3M
  • IPO Year
  • CENN N/A
  • LYRA 2020
  • Fundamental
  • Price
  • CENN $0.24
  • LYRA $6.31
  • Analyst Decision
  • CENN
  • LYRA Hold
  • Analyst Count
  • CENN 0
  • LYRA 1
  • Target Price
  • CENN N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • CENN 8.1M
  • LYRA 48.4K
  • Earning Date
  • CENN 11-11-2025
  • LYRA 11-11-2025
  • Dividend Yield
  • CENN N/A
  • LYRA N/A
  • EPS Growth
  • CENN N/A
  • LYRA N/A
  • EPS
  • CENN N/A
  • LYRA N/A
  • Revenue
  • CENN $30,189,622.00
  • LYRA $770,000.00
  • Revenue This Year
  • CENN N/A
  • LYRA N/A
  • Revenue Next Year
  • CENN N/A
  • LYRA $123.83
  • P/E Ratio
  • CENN N/A
  • LYRA N/A
  • Revenue Growth
  • CENN 143.95
  • LYRA N/A
  • 52 Week Low
  • CENN $0.19
  • LYRA $3.81
  • 52 Week High
  • CENN $1.47
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • CENN 27.96
  • LYRA 39.69
  • Support Level
  • CENN $0.20
  • LYRA $6.25
  • Resistance Level
  • CENN $0.22
  • LYRA $7.30
  • Average True Range (ATR)
  • CENN 0.05
  • LYRA 0.60
  • MACD
  • CENN -0.01
  • LYRA -0.13
  • Stochastic Oscillator
  • CENN 10.18
  • LYRA 8.99

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: